Ascelia Pharma Receives FDA Complete Response Letter on Orviglance NDA

Ascelia Pharma AB ( (SE:ACE)) has issued an announcement. Ascelia Pharma AB, a Malmö-based biotech company focused on orphan oncology treatments for rare cancer-related conditions, is advancing a ...